shutterstock
Solcara Health Blog

Cycle Mapping After 35: What Serial Hormone Testing Shows That One Blood Draw Misses

One well-timed progesterone blood draw can confirm that you ovulated. ASRM's October 2026 committee opinion is direct: "A progesterone concentration >3 ng/mL provides presumptive and sufficient evidence of recent ovulation" [1]. A cycle mapping hormone test answers a different question: how your estrogen and progesterone rose and fell across one whole month. Neither test is built to answer whether you will get pregnant naturally, and AMH predicts that poorly [2] [3].

A smiling woman with a honey-brown braid writes in a paper diary at a marble table, with water, fresh figs and white plantation shutters.

Cycle mapping means collecting hormone samples on many days of one menstrual cycle, usually dried urine at home. The results read as curves instead of one number. That helps with some questions and adds nothing to others. The difference matters more after 35. In ASRM's words, female age is the "single most important predictor of fecundity" [6]. Time spent on the wrong test is time you do not get back.

This guide names the test that answers each common question. It also says when to skip testing and see a fertility specialist.

Which test answers my question?

Names the test that answers each question, from ASRM's 2026 committee opinion. It is not a fertility diagnosis and takes no lab values.

Pick the question you want answered

Confirm I ovulate

Regular cycles, 25 to 35 days, no excess hair growth
ASRM 2026: additional testing to confirm ovulation is not required.[16]
I want proof anyway
One serum progesterone drawn about 1 week before your next expected period. Above 3 ng/mL is presumptive and sufficient evidence of recent ovulation (ASRM 2026).[1][11]

Understand irregular cycles

Irregular or absent periods
ASRM 2026: that history alone is enough to establish an ovulation problem, without more ovulation testing. Ask your clinician to look for the cause.[27]
And trying to conceive
A known condition linked to infertility, such as absent periods, is a reason to start an evaluation right away (ASRM 2026).[29]

Perimenopause symptoms

A month of patterns
A cycle map shows one month of estrogen and progesterone patterns next to your symptoms [30]. Solcara tells patients it does not diagnose a condition [31].
Why one month is a snapshot
Cycle variability was 45% higher at ages 45 to 49 than at 35 to 39 (Apple Women's Health Study, 165,668 cycles).[13]

Trying 6 months or more, age 35 or older

Age band 35 to 40
Book a fertility evaluation: ASRM 2026 advises one after 6 months of trying at 35 or older.[20]
Age band over 40
ASRM 2026 says a more immediate evaluation may be warranted.[20]
An AMH result
Ovarian reserve testing should not be used to exclude women from infertility treatment (ASRM 2026).[19]

General information from ASRM's October 2026 committee opinion and the studies cited on this page. Not a fertility diagnosis. See a fertility specialist when these timelines apply to you.

Key takeaways

  • To confirm ovulation, one serum progesterone drawn about 1 week before your next expected period is enough. A result above 3 ng/mL is presumptive and sufficient evidence of recent ovulation [1] [11].
  • "Day 21" is the right day only for a 28-day cycle. In one study of 612,613 tracked cycles, only 13% were 28 days long [10].
  • A cycle map describes one month of estrogen and progesterone patterns [30]. It does not diagnose a condition [31], and it does not predict pregnancy.
  • AMH estimates egg quantity, not your chance of conceiving naturally. In a JAMA cohort of women aged 30 to 44, low AMH did not lower the predicted chance of pregnancy by 6 cycles (65% vs 62%) [2].
  • At 35 or older, ASRM advises an infertility evaluation after 6 months of trying. Over 40, it says a more immediate evaluation may be warranted [20].

Section 01 / One blood draw

What a single day-3 or day-21 blood test can and cannot tell you

A single blood draw answers one question about one day. A day-3 draw of FSH and estradiol estimates ovarian reserve; ASRM says to measure them together on cycle days 2 to 4 [23]. A luteal progesterone draw confirms that ovulation happened. It cannot tell you whether you will ovulate next month. It cannot grade the quality of your luteal phase either [17].

The name "day-21 progesterone" is the problem. It assumes a 28-day cycle with ovulation on day 14. Real cycles rarely look like that. In 612,613 ovulatory cycles tracked in the Natural Cycles app, only 13% were 28 days long [10]. The authors write that the belief that "ovulation occurs consistently on day 14 of the cycle is not correct" [10]. One caution on that source. The data come from app users, Natural Cycles funded the study, and company employees are among its authors [10].

An older study points the same way. Among 221 women planning a pregnancy, every day from cycle day 6 to day 21 carried at least a 10% chance of being in the fertile window [8]. Only about 30% of women had a fertile window entirely within days 10 to 17 [9]. The authors advise that its timing "can be highly unpredictable, even if their cycles are usually regular" [9].

So ASRM now says to draw luteal progesterone about 1 week before the expected start of the next period, not on a fixed cycle day [11]. Here is our arithmetic from that rule:

Usual cycle lengthASRM-timed progesterone draw (about 1 week before the next period)
25 daysabout day 18
28 daysabout day 21
32 daysabout day 25
35 daysabout day 28

Draw about 1 week before your next period

28-day cycle: about day 21

35-day cycle: about day 28

In a 35-day cycle, a day-21 draw lands about two weeks before the period. A low result then may reflect the timing of the draw, not a missed ovulation.

One more limit. ASRM notes that luteal progesterone can swing sevenfold over a few hours [17]. That is why one value can confirm ovulation but cannot assess the luteal phase [17].

Section 02 / Cycle mapping

What serial cycle mapping measures across a month

Serial cycle mapping measures estrogen and progesterone, or their breakdown products, on many days of one cycle. DUTCH Cycle Mapping, for example, reports nine estrogen and progesterone measurements from first-morning urine samples, adjusted to the length of your cycle [30]. The result is a picture of one month's follicular, ovulatory and luteal phases. Not a verdict.

A hand presses a coral dot sticker onto a blank month planner on a marble table, beside a dish of colored stickers, figs and a cup of tea.

A map shows shape: whether progesterone rose after ovulation, how long the rise lasted, and how those curves line up with the days you had spotting, migraines or mood changes. One blood draw cannot show a pattern like that.

The vendor sets its own limits. DUTCH says the test is not needed if you are postmenopausal, on birth control, or have cycles that follow the expected pattern [30]. At Solcara, menstrual mapping pairs about a month of home dried urine samples with daily notes on bleeding, pain, mood and other symptoms. The practice tells patients before they start that a map describes patterns and does not diagnose a condition [31].

Cheaper home methods exist, and ASRM rates them plainly. Urinary LH kits give indirect evidence of ovulation, with false-positive and false-negative results [14]. ASRM calls basal body temperature charting "an inexpensive, although often unreliable method of predicting ovulation" [15].

One mapped month is still one month. In the Apple Women's Health Study of 165,668 cycles, cycle variability was lowest at ages 35 to 39 and 45% higher at ages 45 to 49 [13]. In the Natural Cycles data, the luteal phase averaged 12.4 days and barely changed with age, while the follicular phase shortened [12].

TestThe question it answersWhat it cannot tell youMarket price (read November 9, 2026)Evidence
One serum progesterone, about 1 week before the next periodDid I ovulate this cycle?Luteal phase quality; next month; fertilityNot priced hereASRM 2026 [1] [11] [17]
Day 2 to 4 FSH and estradiolRough estimate of ovarian reserveChance of natural pregnancyNot priced hereASRM 2026 [23]; Steiner 2017 [2]
AMH blood testRoughly how many eggs remainChance of natural pregnancyQuest AMH: $135 plus a $6 physician fee [5]ASRM 2026 [18]; Steiner 2017 [2]
Cycle map (about a month of urine samples)What my estrogen and progesterone did across one month, next to my symptomsA diagnosis; future cycles; fertilityDUTCH Cycle Mapping (Female Only): $550 [4]Vendor description [30]; pattern context, not a diagnosis [31]

Want to see what a whole-month map would add for you? Learn about menstrual cycle mapping at Solcara, including what it can and cannot show.

Section 03 / ASRM 2026

What ASRM's 2026 opinion says about confirming ovulation

ASRM's 2026 fertility evaluation opinion says that if you are not hirsute and your cycles are regular, between 25 and 35 days, "additional testing to confirm ovulation is not required" [16]. When a test is needed, one serum progesterone drawn about 1 week before your next expected period is enough. A result above 3 ng/mL is presumptive and sufficient evidence of recent ovulation [1] [11].

The opinion was published online on October 20, 2026, and replaces the 2021 version [1]. It starts with your menstrual history. In most ovulatory women, ASRM says, cycles come every 25 to 35 days with a consistent pattern [24]. Some variation is normal. In a study ASRM cites, the gap between periods changed by more than 5 days in 56% of patients within 6 months [24].

Ovulation problems are common in infertility. ASRM reports ovulatory dysfunction in about 40% of women with infertility [26]. Among the most common causes, it lists PMOS (polyendocrine metabolic ovarian syndrome, formerly called polycystic ovary syndrome or PCOS), obesity, perimenopause, thyroid disease and high prolactin [26].

Two groups need a different approach. First, irregular or absent periods. ASRM says that history alone is enough to establish an ovulation problem, without more ovulation testing. The next step is finding the cause [27]. Second, excess hair growth. Only about 60% of women with regular periods and hirsutism ovulate regularly, and ASRM says a luteal progesterone should be considered for them [27].

The opinion also sets a ceiling. A single progesterone value can confirm ovulation "but not to assess the quality of the luteal phase" [17]. So you do not need a cycle map to answer "did I ovulate?" A question about the pattern of a whole month is a separate question. It needs a separate test.

Section 04 / AMH

Why AMH does not predict natural fertility

Ovarian reserve means the number of eggs left in your ovaries. AMH, anti-Mullerian hormone, is a blood marker of that number. It does not measure egg quality, and it predicts natural pregnancy poorly. In a meta-analysis of 11 studies (4,388 participants) that ASRM cites, AMH had an area under the curve of 0.59 for spontaneous pregnancy, where 0.5 is a coin flip [18].

The best-known study is a JAMA cohort of 750 women aged 30 to 44 [2]. None had a history of infertility. All had been trying for 3 months or less. Women with low AMH, under 0.7 ng/mL, had a 65% predicted chance of conceiving by 6 cycles [2]. Women with normal AMH had 62%. The difference was not significant [2]. A high blood FSH did not change the odds either: 63% vs 62% [2].

Group in Steiner et al., JAMA 2017 (750 women aged 30 to 44) [2]Predicted chance of conceiving by 6 cyclesBy 12 cycles
Low AMH (under 0.7 ng/mL)65%84%
Normal AMH62%75%
What each fertility hormone test predicts750 women aged 30 to 44, no infertility history, trying 3 months or less (Steiner et al., JAMA 2017) [2]

Predicted chance of conceiving

Low AMH (under 0.7 ng/mL)

By 6 cycles65%By 12 cycles84%

Normal AMH

By 6 cycles62%By 12 cycles75%

The difference was not significant. [2]

A separate cohort of 3,150 women linked AMH under 1 ng/mL to a lower chance of pregnancy [28]

Source: Steiner AZ et al., JAMA 2017; ASRM 2026 committee opinion. Date range: 2017 to 2026. Read November 9, 2026. [2][28]

The evidence is not one-sided, and ASRM says so. A separate cohort of 3,150 women linked AMH under 1 ng/mL to a lower chance of pregnancy [28]. ASRM concludes that the studies conflict, and that AMH reflects egg quantity but not quality [28]. Its 2020 opinion put it plainly: ovarian reserve markers are poor predictors of reproductive potential independently from age [3].

The lab agrees. Quest's own AMH test page says the test helps assess egg supply but does not predict fertility [5].

AMH still has a job in planning fertility treatment. But ASRM is clear: "Ovarian reserve testing should not be used to exclude women from infertility treatment" [19]. ASRM also says current guidelines do not recommend routine serial AMH testing. One value, read with your age and history, is the standard [25].

Section 05 / When to test

When to test, and when to see a fertility specialist instead

At 35 or older, ASRM advises starting an infertility evaluation after 6 months of regular unprotected intercourse without pregnancy. Under 35, the mark is 12 months. Over 40, ASRM says a more immediate evaluation may be warranted [20]. A known condition linked to infertility, such as absent periods, is a reason to start right away [29]. Take that evaluation to a fertility specialist, a reproductive endocrinologist.

Age changes the math. In the PRESTO cohort of 2,962 North American couples, 62.0% of women aged 28 to 30 were pregnant within 6 cycles [22]. For women aged 40 to 45, it was 27.6% [22]. Compared with ages 21 to 24, the per-cycle chance of conceiving was 0.82 times as high at 34 to 36 (not statistically significant), 0.60 at 37 to 39 and 0.40 at 40 to 45 [22].

Lower odds are not zero odds. In a European cohort of 782 couples, 18% of women aged 35 to 39 were estimated to be unable to conceive within a year [7]. Sterility stayed at about 1% at every age [7]. And depending on age, 43% to 63% of the infertile couples were estimated to conceive with another year of trying [7]. CDC estimates that about 1 in 5 married women aged 15 to 49 with no prior births cannot get pregnant after 1 year of trying [21]. An evaluation at 6 months is not a judgment on your chances. It is a way to find a fixable cause sooner.

Use these steps to decide:

  1. Name your question first. "Did I ovulate?", "Why do my symptoms swing each month?" and "Can I get pregnant?" are three questions with three different tests.
  2. If your cycles are regular, 25 to 35 days, and you do not have excess hair growth, you do not need a test to confirm ovulation [16]. If you want proof, ask for one progesterone draw timed about 1 week before your next period [11].
  3. If your cycles are irregular or absent, skip the ovulation test. Ask your clinician to look for the cause [27].
  4. If you want to see a whole month of hormone patterns next to your symptoms, a cycle map answers that question. It is not a fertility test.
  5. If you are 35 or older and have tried for 6 months, book a fertility evaluation [20]. Over 40, ask for an evaluation sooner [20] [21].
  6. Do not let one AMH number decide for you [19].

My view: name the question before you pay for any test.

Section 06 / Questions

Cycle Mapping Questions Answered

Is a day 21 progesterone test accurate?

The test is reliable when it is drawn at the right time [11]. The day is often wrong. ASRM says to draw progesterone about 1 week before your next expected period, not on a fixed day such as day 21 [11]. Day 21 fits a 28-day cycle. In a 32-day cycle, the right day is closer to day 25. A result above 3 ng/mL is presumptive and sufficient evidence of recent ovulation [1]. A low result from a mistimed draw does not prove that you did not ovulate.

What does cycle mapping test for?

A cycle map measures estrogen and progesterone, or their metabolites, on many days of one cycle. DUTCH Cycle Mapping reports nine measurements from first-morning urine samples [30]. At Solcara, the samples are paired with a daily symptom diary [31]. A map shows the shape of one month. It does not diagnose a condition or predict pregnancy.

Does a low AMH mean infertility?

No. AMH estimates how many eggs remain, not your chance of natural conception. In a JAMA cohort of women aged 30 to 44 trying for 3 months or less, low AMH did not significantly change the predicted chance of pregnancy by 6 cycles (65% vs 62%) [2]. In the meta-analysis ASRM cites, AMH had an area under the curve of 0.59 for spontaneous pregnancy [18]. ASRM says ovarian reserve testing should not be used to exclude women from infertility treatment [19].

How long should I try before seeing a fertility specialist after 35?

Six months. ASRM advises an infertility evaluation after 6 months of trying at 35 or older, and a more immediate evaluation over 40 [20]. CDC lists irregular or absent periods as a reason to seek care without waiting [21].

Is DUTCH cycle mapping worth the cost?

That turns on your question. DUTCH lists its Cycle Mapping (Female Only) kit at $550 on its official shop page, read November 9, 2026 [4]. If you only need to know whether you ovulate, one timed progesterone draw answers that [1]. If you want a month of hormone patterns next to your symptoms, a map is the test built for that. DUTCH itself says the test is not needed if your cycles follow the expected pattern [30].

Section 07 / Bottom line

Bottom line: match the test to the question

One timed progesterone draw tells you whether you ovulated [1]. A cycle map tells you what one month of hormones looked like next to your symptoms. AMH tells you roughly how many eggs remain, and not whether you will conceive [2] [18].

After 35, the calendar matters more than any lab report. Female age is the single most important predictor of fecundity [6]. If you are 35 or older and have tried for 6 months, book a fertility evaluation [20], ideally with a fertility specialist. If your periods are irregular or absent, do not wait [21] [29].

Solcara Health sees patients at 496 Bramson Ct in Mount Pleasant and at The Longevity Club, 163 Rutledge Ave in downtown Charleston. To talk through which test fits your question, explore our fertility and gynecology care or read what a longevity blood panel measures. You can also call 843-981-0870 or book online.

References

  1. [1] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (ovulation, serum progesterone). Fertil Steril 2026 (PMID 42901815). October 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
  2. [2] Steiner AZ et al. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age. JAMA 2017 (PMID 29049585). October 2017. https://doi.org/10.1001/jama.2017.14588
  3. [3] Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril 2020 (PMID 33280722). December 2020. https://doi.org/10.1016/j.fertnstert.2020.09.134
  4. [4] DUTCH (Precision Analytical). Shop: DUTCH Cycle Mapping (Female Only). Read November 9, 2026. https://shop.dutchtest.com/shop/
  5. [5] Quest Health. AMH Marker Test. Read November 9, 2026. https://www.questhealth.com/product/amh-marker-test/37227M.html
  6. [6] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (female age). Fertil Steril 2026. October 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
  7. [7] Dunson DB, Baird DD, Colombo B. Increased infertility with age in men and women. Obstet Gynecol 2004 (PMID 14704244). January 2004. https://doi.org/10.1097/01.aog.0000100153.24061.45
  8. [8] Wilcox AJ, Dunson D, Baird DD. The timing of the "fertile window" in the menstrual cycle: day specific estimates from a prospective study. BMJ 2000 (PMID 11082086). November 2000. https://doi.org/10.1136/bmj.321.7271.1259
  9. [9] Wilcox AJ, Dunson D, Baird DD. The timing of the "fertile window" in the menstrual cycle (conclusions). BMJ 2000. November 2000. https://doi.org/10.1136/bmj.321.7271.1259
  10. [10] Bull JR et al. Real-world menstrual cycle characteristics of more than 600,000 menstrual cycles. NPJ Digit Med 2019 (PMID 31482137; funded by Natural Cycles Nordic AB). August 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC6710244/
  11. [11] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (timing of the progesterone draw). Fertil Steril 2026. October 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
  12. [12] Bull JR et al. Real-world menstrual cycle characteristics (phase lengths by age, Table 2). NPJ Digit Med 2019. August 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC6710244/
  13. [13] Li H et al. Menstrual cycle length variation by demographic characteristics from the Apple Women's Health Study. NPJ Digit Med 2023 (PMID 37248288). May 2023. https://doi.org/10.1038/s41746-023-00848-1
  14. [14] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (ovulation predictor kits). Fertil Steril 2026. October 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
  15. [15] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (basal body temperature). Fertil Steril 2026. October 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
  16. [16] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (conclusions, regular cycles). Fertil Steril 2026. October 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
  17. [17] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (single progesterone value). Fertil Steril 2026. October 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
  18. [18] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (AMH meta-analysis). Fertil Steril 2026. October 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
  19. [19] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (conclusions, ovarian reserve). Fertil Steril 2026. October 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
  20. [20] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (when to evaluate). Fertil Steril 2026. October 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
  21. [21] Centers for Disease Control and Prevention. Infertility FAQs. May 15, 2024. https://www.cdc.gov/reproductive-health/infertility-faq/index.html
  22. [22] Wesselink AK et al. Age and fecundability in a North American preconception cohort study (PRESTO). Am J Obstet Gynecol 2017 (PMID 28917614). December 2017. https://doi.org/10.1016/j.ajog.2017.09.002
  23. [23] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (ovarian reserve tests). Fertil Steril 2026. October 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
  24. [24] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (menstrual history). Fertil Steril 2026. October 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
  25. [25] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (serial AMH). Fertil Steril 2026. October 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
  26. [26] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (ovulatory dysfunction). Fertil Steril 2026. October 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
  27. [27] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (irregular cycles and hirsutism). Fertil Steril 2026. October 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
  28. [28] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (conflicting AMH studies). Fertil Steril 2026. October 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
  29. [29] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (immediate evaluation). Fertil Steril 2026. October 2026. https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
  30. [30] DUTCH (Precision Analytical). DUTCH Cycle Mapping. Read November 9, 2026. https://dutchtest.com/cycle-mapping
  31. [31] Solcara Health. Menstrual Mapping in Charleston and Mt. Pleasant, SC. Updated October 4, 2026. https://www.solcarahealth.com/services/menstrual-mapping
Ashley Harwyn, PA-C, smiling in front of a woven rattan chair.

About the author

Ashley Harwyn, PA-C, ABAAHP

Full bio

This article is for general education and is not medical advice. It is not a fertility diagnosis and does not create a provider-patient relationship. Talk with a licensed clinician about your own situation, and see a fertility specialist (a reproductive endocrinologist) when the timelines in this article apply to you. Solcara Health, 496 Bramson Ct, Ste 120, Mount Pleasant, SC 29464 and 163 Rutledge Ave, Ste 202, Charleston, SC 29403. 843-981-0870.

Return to blog